15250-m-cuypers

222 Chapter 11 15. Holmes-Rovner M, Montgomery JS, Rovner DR, Scherer LD, Whitfield J, Kahn VC, et al. Informed Decision Making: Assessment of the Quality of Physician Communication about Prostate Cancer Diagnosis and Treatment. Medical Decision Making. 2015;35(8):999-1009. 16. Munro S, Stacey D, Lewis KB, Bansback N. Choosing treatment and screening options congruent with values: Do decision aids help? Sub-analysis of a systematic review. Patient Education and Counseling. 2016;99(4):491-500. 17. Fagerlin A, Pignone M, Abhyankar P, Col N, Feldman-Stewart D, Gavaruzzi T, et al. Clarifying values: an updated review. BMC Med Inform Decis Mak. 2013;13(Suppl 2):S8. 18. Dolan JG, Cherkasky OA, Chin N, Veazie PJ. Decision Aids. Medical Decision Making. 2015;35(8):979-86. 19. Weernink MGM, van Til JA, van Vugt JPP, Movig KLL, Groothuis-Oudshoorn CGM, Ijzerman MJ. Involving Patients in Weighting Benefits and Harms of Treatment in Parkinson's Disease. PLOS ONE. 2016;11(8):e0160771. 20. Valerie FR. A Theory of Medical Decision Making and Health: Fuzzy Trace Theory. Medical Decision Making. 2008;28(6):850-65. 21. O'Connor AM, Légaré F, Stacey D. Risk communication in practice: the contribution of decision aids. BMJ. 2003;327(7417):736-40. 22. Trevena LJ, Zikmund-Fisher BJ, Edwards A, Gaissmaier W, Galesic M, Han PK, et al. Presenting quantitative information about decision outcomes: a risk communication primer for patient decision aid developers. BMC Medical Informatics and Decision Making. 2013;13(2):S7. 23. Adsul P, Wray R, Spradling K, Darwish O, Weaver N, Siddiqui S. Systematic Review of Decision Aids for Newly Diagnosed Patients with Prostate Cancer Making Treatment Decisions. The Journal of Urology. 2015;194(5):1247-52. 24. Violette PD, Agoritsas T, Alexander P, Riikonen J, Santti H, Agarwal A, et al. Decision aids for localized prostate cancer treatment choice: Systematic review and meta-analysis. CA: A Cancer Journal for Clinicians. 2015;65(3):239-51. 25. Porter ME. Value-Based Health Care Delivery. Annals of Surgery. 2008;248(4):503-9. 26. Raghupathi W, Raghupathi V. Big data analytics in healthcare: promise and potential. Health information science and systems. 2014;2(1):3. 27. Mamawala MM, Rao K, Landis P, Epstein JI, Trock BJ, Tosoian JJ, et al. Risk prediction tool for grade re-classification in men with favourable-risk prostate cancer on active surveillance. BJU International. 2017;120(1):25-31. 28. Coley RY, Fisher AJ, Mamawala M, Carter HB, Pienta KJ, Zeger SL. A Bayesian hierarchical model for prediction of latent health states from multiple data sources with application to active surveillance of prostate cancer. Biometrics. 2017;73(2):625-34. 29. Bul M, Zhu X, Valdagni R, Pickles T, Kakehi Y, Rannikko A, et al. Active Surveillance for Low-Risk Prostate Cancer Worldwide: The PRIAS Study. European Urology. 2013;63(4):597-603. 30. Louie KS, Seigneurin A, Cathcart P, Sasieni P. Do prostate cancer risk models improve the predictive accuracy of PSA screening? A meta-analysis. Annals of Oncology. 2015;26(5):848- 64.